Kazia Therapeutics Ltd (KZIA) Stock Price, Quote, News & History

KZIANASDAQ
$14.60
0.815.87%
At close: Aug 26, 5:00 PM EST
$14.99
0.392.67%
After Hours: 6:41 PM EST

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-14.40M
Investing Cash Flow (TTM)
-
Financing Cash Flow (TTM)
81.56M
Free Cash Flow (TTM)
-14.40M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
67.17M

Analyst Trends and Forecast

1
Apr
1
Jun
2
Jul
1
Aug
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$108.18M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
1022.96
PB Ratio (TTM)
4.74
Earnings Yield % (TTM)
-55.20%
Earnings Yield % (FWD)
-12.36%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$2.92

Company Debt

Total Debt
$98.81K
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$69.46M
Debt to Equity
0.00
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$13.79
Close
$14.60
Volume / Avg.
100.85K / 186.96K
Day Range
$13.62 - $14.79
52 Wk Range
4.86 - 17.40
Market Cap
$171.29M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
62
Short Interest
4.9%
Days to Cover
2.72

About

Sector
Health Care
Industry
Biotechnology
Kazia Therapeutics Ltd is a biotechnology company focused on pharmaceutical drug development in oncology. The company has a portfolio of development candidates across various technologies targeting multiple cancer indications. Its primary program is ...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Kazia Therapeutics (KZIA) stock?

A

You can purchase shares of Kazia Therapeutics (NASDAQ:KZIA) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Kazia Therapeutics (KZIA) competitors?

Q

What is the forecast, or price target, for Kazia Therapeutics (KZIA) stock?

A

Kazia Therapeutics has a consensus price target of $24.71.

Q

What is the current price for Kazia Therapeutics (KZIA)?

A

The stock price for Kazia Therapeutics (NASDAQ: KZIA) is $14.99 last updated August 26, 2026 at 6:41 PM EDT.

Q

Does Kazia Therapeutics (KZIA) pay a dividend?

A

There are no upcoming dividends for Kazia Therapeutics.

Q

When is Kazia Therapeutics (NASDAQ:KZIA) reporting earnings?

A

Kazia Therapeutics does not have any upcoming earnings scheduled.

Q

Is Kazia Therapeutics (KZIA) going to split?

A

There is no upcoming split for Kazia Therapeutics.

Q

What sector and industry does Kazia Therapeutics (KZIA) operate in?

A

Kazia Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.